SkinHealth Systems (SKIN) Gross Margin (2020 - 2026)
SkinHealth Systems' (SKIN) quarterly Gross Margin came in at 68.42% in Q2 2026, up 560.0% year-over-year from 10.37% in Q2 2025, and little changed quarter-over-quarter from 68.46% in Q1 2026.
Powered by 
Analysis
SkinHealth Systems (SKIN) Gross Margin (2020 - 2026) Analysis & Trends
SkinHealth Systems (SKIN) has reported Gross Margin for 7 consecutive years, with 68.42% the latest figure, recorded in Q2 2026.
- On a quarterly basis, Gross Margin rose 560.0% year-over-year to 68.42% in Q2 2026; TTM through Jun 2026 was 66.35%, a 485.0% increase from a year earlier, with the FY2025 full-year figure at 65.28%, up 1075.0% from the prior year.
- Gross Margin was 68.42% for Q2 2026 at SkinHealth Systems, roughly flat from 68.46% in the prior quarter.
- Over five years, Gross Margin peaked at 69.82% in Q1 2025 and troughed at 12.89% in Q3 2023.
- A 5-year average of 58.01% and a median of 63.6% in 2025 frame the typical range for Gross Margin.
- Across the five-year window, Gross Margin slumped 8200 bps in 2023 and soared 6447 bps in 2024, its largest moves.
- Over 5 years, Gross Margin stood at 67.76% in 2022, then slumped by 30 bps to 47.19% in 2023, then surged by 33 bps to 62.69% in 2024, then gained by 3 bps to 64.39% in 2025, then grew by 6 bps to 68.42% in 2026.
- The last three Gross Margin figures came in at 68.42% (Q2 2026), 68.46% (Q1 2026), and 64.39% (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.03 Bn | 178.43 Bn | 7.27 Bn | 57.71% |
| 2 | Intuitive Surgical | 124.34 Bn | 119.12 Bn | 1.96 Bn | 67.78% |
| 3 | Medtronic | 118.76 Bn | 109.94 Bn | 6.34 Bn | 64.99% |
| 4 | Stryker | 105.91 Bn | 102.43 Bn | 4.50 Bn | 68.27% |
| 5 | Boston Scientific | 66.28 Bn | 65.74 Bn | 3.85 Bn | 70.71% |
| 6 | Edwards Lifesciences | 50.14 Bn | 45.89 Bn | 1.35 Bn | 77.46% |
| 7 | Alcon | 34.18 Bn | 32.72 Bn | 1.68 Bn | 60.21% |
| 8 | Dexcom | 32.28 Bn | 30.34 Bn | 830.00 Mn | 63.44% |
| 9 | Resmed | 32.24 Bn | 30.77 Bn | 861.22 Mn | 58.84% |
| 10 | SkinHealth Systems | 93.22 Mn | -112.85 Mn | 49.34 Mn | 68.42% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 68.42% |
| Mar 31, 2026 | 68.46% |
| Dec 31, 2025 | 64.39% |
| Sep 30, 2025 | 64.59% |
| Jun 30, 2025 | 62.81% |
| Mar 31, 2025 | 69.82% |
| Dec 31, 2024 | 62.69% |
| Sep 30, 2024 | 51.58% |
| Jun 30, 2024 | 45.19% |
| Mar 31, 2024 | 59.41% |
| Dec 31, 2023 | 47.19% |
| Sep 30, 2023 | -12.89% |
| Jun 30, 2023 | 57.78% |
| Mar 31, 2023 | 62.71% |
| Dec 31, 2022 | 67.76% |
| Sep 30, 2022 | 69.11% |
| Jun 30, 2022 | 67.65% |
| Mar 31, 2022 | 67.47% |
| Dec 31, 2021 | 68.65% |
| Sep 30, 2021 | 67.61% |